Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues.
about
Coarse-grained modeling of mucus barrier propertiesMicro- and macrorheology of mucusNanoparticle based insulin delivery system: the next generation efficient therapy for Type 1 diabetesMucus penetrating nanoparticles: biophysical tool and method of drug and gene deliveryAnti-PEG immunity: emergence, characteristics, and unaddressed questions.In vitro and in vivo models for the study of oral delivery of nanoparticlesA holistic approach to targeting disease with polymeric nanoparticlesOral delivery of glucagon-like peptide-1 and analogs: alternatives for diabetes control?Method for quantitative study of airway functional microanatomy using micro-optical coherence tomographyFood-associated stimuli enhance barrier properties of gastrointestinal mucusThe uptake of soluble and particulate antigens by epithelial cells in the mouse small intestineMucoadhesive nanoparticles may disrupt the protective human mucus barrier by altering its microstructureSize selectivity of intestinal mucus to diffusing particulates is dependent on surface chemistry and exposure to lipidsDelivery of RNAi Therapeutics to the Airways-From Bench to BedsideParticle tracking in drug and gene delivery research: State-of-the-art applications and methodsHighly compacted biodegradable DNA nanoparticles capable of overcoming the mucus barrier for inhaled lung gene therapyCharacterization of respiratory drug delivery with enhanced condensational growth using an individual path model of the entire tracheobronchial airwaysEngineered nanomaterials in food: implications for food safety and consumer healthBioavailability, distribution and clearance of tracheally-instilled and gavaged uncoated or silica-coated zinc oxide nanoparticlesEnhanced transferrin receptor expression by proinflammatory cytokines in enterocytes as a means for local delivery of drugs to inflamed gut mucosaBarriers to inhaled gene therapy of obstructive lung diseases: A reviewPolymeric Nanostructures for Imaging and TherapyNanoparticles for oral delivery: targeted nanoparticles with peptidic ligands for oral protein delivery.Progress in antiretroviral drug delivery using nanotechnologySpray-dried powders enhance vaginal siRNA delivery by potentially modulating the mucus molecular sieve structureThe importance of the vaginal delivery route for antiretrovirals in HIV prevention.Artificial micromotors in the mouse's stomach: a step toward in vivo use of synthetic motors.Polymeric micelles, a promising drug delivery system to enhance bioavailability of poorly water-soluble drugs.Fluidization of nanopowders: a review.Human immunodeficiency virus type 1 is trapped by acidic but not by neutralized human cervicovaginal mucus.Use of single-site-functionalized PEG dendrons to prepare gene vectors that penetrate human mucus barriersIgG in cervicovaginal mucus traps HSV and prevents vaginal herpes infectionsThe mechanism for increasing the oral bioavailability of poorly water-soluble drugs using uniform mesoporous carbon spheres as a carrier.Nanodelivery in airway diseases: challenges and therapeutic applications.Impact of hydrogel nanoparticle size and functionalization on in vivo behavior for lung imaging and therapeuticsTransient antibody-mucin interactions produce a dynamic molecular shield against viral invasionNanoparticles reveal that human cervicovaginal mucus is riddled with pores larger than viruses.Formulation and characterization of nanoemulsion intranasal adjuvants: effects of surfactant composition on mucoadhesion and immunogenicity.Understanding peroral absorption: regulatory aspects and contemporary approaches to tackling solubility and permeability hurdlesEssential oils loaded in nanosystems: a developing strategy for a successful therapeutic approach
P2860
Q24606537-787422D0-C84B-41A9-A6CC-1C39A2861FD3Q24643968-CC45BDCB-D9C8-4F1E-9822-9EFB0E0803C4Q26779447-DC206817-3EC0-49F6-B784-BC1220C5DDD6Q26823541-BE214533-9CDC-490C-B0C4-C736114347C8Q26825556-220A2EB4-20AA-45BE-963D-74BD78EE58A7Q26829514-E90140B8-12DA-4F34-BF04-B7AD06AF29A8Q26865163-5D7452E8-E7C6-4762-8E8D-B233F5790065Q27023585-5B685E6C-5A7A-4362-9227-BCB1967C7C52Q27319331-A247CD4C-13C7-4C09-85DD-3FD803D7661CQ27329920-A76974FF-2719-4E4B-BFC0-6E445FFDBC5FQ27329973-76CD780C-28FF-4624-8C62-799B18688C90Q27334360-2C766D29-44D6-4C2F-B7BE-A7651984E44BQ27334566-B58ACF5B-933D-42FA-8E77-262A0B5280F5Q28067306-B2EF8E21-A6CF-4328-8A81-533665DA2BE1Q28087396-21C8CA08-3290-4AB3-A568-974780E23A3BQ28383844-F28FA630-11F2-42D8-A472-327131F888ECQ28386376-BBF4E6C5-D4C0-4CAE-B12B-36D08AEB5C15Q28389204-F8543881-0BD0-4701-98DF-2CE0D1757B63Q28397883-05838C2D-9246-4F7A-AE42-90B5712A9CA3Q28476816-52A30D52-C490-4A2A-B74F-D68BC5E6F4C9Q29248141-001C78DB-CD1E-489D-B44F-9E1620118367Q30372383-04809FCA-B284-4755-94A1-21791A844916Q30391507-A52EDB5A-15EB-40EA-80CE-8E3306C075B2Q30395011-A4C910C2-B6BB-4055-9A7D-8826A3AA9F90Q30403415-BFD8AD8B-0364-4AE4-A1ED-B430E98F717AQ30414890-BBF8BBCD-4855-46B9-B86A-15324EEDDE4BQ30420047-218BB723-7186-4717-90F4-73E1BC37CCE3Q30451024-DA430900-2388-4905-A55B-AA219F72D72FQ30467642-3B480438-67C7-4886-B766-82A109CABD59Q30491417-BB1EEA80-8DA3-492C-8759-BBED0B8BEF02Q30546346-B4DAC118-D536-4D74-835C-36686063B0AAQ30585914-0C1DBA8F-DCE8-4655-866E-B9031FA35550Q31161857-93E2EB35-DB59-4A44-AB71-F7005FC48287Q33483926-B6E8D4A6-7B21-469A-8DC5-DEEA4BC87AAEQ33583948-7CD90D08-7691-4081-9674-336B6C48F6DAQ33595754-2E58E587-ACCB-4066-B7BF-6181A7DC4058Q33640386-3475A42D-BFAF-43A3-92A3-D3F8794EADD7Q33650861-09AAC4C6-F85F-4966-86B2-6B121B5320B1Q33683206-0DF9315D-D99A-4E36-9490-73EE6B5615B3Q33757486-19385373-9AF1-4187-ABC2-6A5F8BAE7EA0
P2860
Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 13 December 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues.
@en
Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues.
@nl
type
label
Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues.
@en
Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues.
@nl
prefLabel
Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues.
@en
Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues.
@nl
P2860
P1476
Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues.
@en
P2093
Samuel K Lai
Ying-Ying Wang
P2860
P304
P356
10.1016/J.ADDR.2008.11.002
P407
P50
P577
2008-12-13T00:00:00Z